TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 178 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,641,608 | +40.9% | 92,277 | +20.4% | 0.01% | +50.0% |
| Q1 2024 | $1,165,329 | +38.7% | 76,616 | +55.8% | 0.00% | +33.3% |
| Q4 2023 | $839,977 | +104.3% | 49,179 | 0.0% | 0.00% | +50.0% |
| Q3 2023 | $411,136 | -67.7% | 49,179 | -4.0% | 0.00% | -60.0% |
| Q2 2023 | $1,272,081 | +38.1% | 51,211 | -16.4% | 0.01% | +25.0% |
| Q1 2023 | $921,305 | -51.1% | 61,257 | -61.5% | 0.00% | -55.6% |
| Q4 2022 | $1,884,637 | +95.1% | 159,310 | -2.4% | 0.01% | +80.0% |
| Q3 2022 | $966,000 | +79.2% | 163,215 | +28.8% | 0.01% | +66.7% |
| Q2 2022 | $539,000 | +450.0% | 126,706 | +1135.0% | 0.00% | – |
| Q1 2022 | $98,000 | -66.3% | 10,260 | +36.7% | 0.00% | -100.0% |
| Q2 2021 | $291,000 | -49.9% | 7,505 | -37.7% | 0.00% | -66.7% |
| Q1 2021 | $581,000 | +157.1% | 12,050 | +3.9% | 0.00% | +200.0% |
| Q2 2020 | $226,000 | – | 11,598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Jetstream Capital LLC | 200,000 | $7,758,000 | 5.97% |
| Lion Point Capital, LP | 609,128 | $23,628,000 | 4.08% |
| RA Capital Management | 3,342,743 | $129,665,000 | 2.08% |
| Ghost Tree Capital, LLC | 180,000 | $6,982,000 | 1.92% |
| Nicholas Investment Partners, LP | 660,964 | $25,639,000 | 1.61% |
| ARDSLEY ADVISORY PARTNERS LP | 350,000 | $13,577,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 414,949 | $16,096,000 | 1.30% |
| Spotlight Asset Group, Inc. | 75,000 | $2,909,000 | 1.12% |
| ACT CAPITAL MANAGEMENT, LLC | 55,000 | $2,134,000 | 1.10% |
| Pier Capital, LLC | 280,486 | $10,880,000 | 1.09% |